calendar
7,990 catalysts · 3,350 8k filing · 1,368 grant · 1,000 device adverse event · 615 approval · 582 earnings · 476 device 510k
7,990 catalysts · 3,350 8k filing · 1,368 grant · 1,000 device adverse event · 615 approval · 582 earnings · 476 device 510k
Sponsor: NEXTWAVE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL
Product code: HRS. Advisory committee: Orthopedic. Type: Traditional
Product code: FDT. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: HGX. Advisory committee: Obstetrics/Gynecology. Type: Traditional
Product code: NFT. Advisory committee: Clinical Toxicology. Type: Traditional
Product code: PDZ. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: MBH. Advisory committee: Orthopedic. Type: Traditional
Product code: PBX. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: PCH. Advisory committee: Microbiology. Type: Traditional
Product code: MBI. Advisory committee: Orthopedic. Type: Special
Product code: LNH. Advisory committee: Radiology. Type: Traditional
Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: APPR
Supplement type: 135 Review Track For 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: APPR
Supplement type: Normal 180 Day Track. Product code: NVY. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: QQK. Advisory committee: GU. Decision: APPR
Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30
NS grant. $137,687. PI: Jelly Hubertus Maria Soffers
GM grant. $393,250. PI: Liana Twardosz Burghardt
HL grant. $1,151,500. PI: Ira A Tabas
MH grant. $2,305,031. PI: Andre Berndt
GM grant. $617,574. PI: Kathleen Collins
GM grant. $300,872. PI: Wentao Li
Sponsor: AYTU. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL
Sponsor: KINIKSA PHARMACEUTICALS (UK), LTD.. Form: VIAL. Route: SINGLE-USE
Sponsor: NEXTWAVE PHARMS. Form: TABLET, EXTENDED RELEASE, CHEWABLE. Route: ORAL
Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: INNOGENIX. Form: TABLET. Route: ORAL
Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION
Sponsor: BAYER. Form: TABLET. Route: ORAL
Sponsor: P AND L. Form: GEL. Route: TOPICAL
Sponsor: SPRINGWORKS. Form: TABLET. Route: ORAL
Sponsor: DIFGEN PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Product code: EIH. Advisory committee: Dental. Type: Traditional
Product code: NVK. Advisory committee: General, Plastic Surgery. Type: Traditional
Advisory committee: Unknown. Type: Traditional
Product code: IYN. Advisory committee: Radiology. Type: Traditional
Product code: DZE. Advisory committee: Dental. Type: Traditional
Product code: HSB. Advisory committee: Orthopedic. Type: Traditional
Product code: OAS. Advisory committee: Radiology. Type: Traditional
Product code: OWB. Advisory committee: Radiology. Type: Traditional
Product code: ELC. Advisory committee: Dental. Type: Traditional
Product code: MAF. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NIP. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: NIP. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30
Supplement type: Normal 180 Day Track. Product code: PJG. Advisory committee: PA. Decision: APPR
Supplement type: 30-Day Notice. Product code: NIO. Advisory committee: CV. Decision: OK30